Clinical and electrophysiological characteristics of patients having atrial flutter with 1:1 atrioventricular conduction

Europace

Volumn 10, Issue 3, 2008, Pages 284-288

  Kawabata, Mihoko ^a   Hirao, Kenzo ^a   Higuchi, Kouji ^a   Sasaki, Takeshi ^a   Furukawa, Toshiyuki ^a   Okada, Hiroyuki ^a   Hachiya, Hitoshi ^a   Isobe, Mitsuaki ^a  

^a Tokyo Medical and Dental University ^*  (Japan)

Author keywords

1:1 AV conduction; Atrial flutter; Exercise; Sympathetic tone; Syncope

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; APRINDINE; ATENOLOL; BEPRIDIL; CIBENZOLINE; DIGOXIN; DISOPYRAMIDE; FLECAINIDE; PILSICAINIDE; PROCAINAMIDE; PROPAFENONE; SEMATILIDE; SOTALOL; VERAPAMIL;

ADOLESCENT; ADULT; AGED; ARTICLE; ATRIOVENTRICULAR CONDUCTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM FLUTTER; HEART ELECTROPHYSIOLOGY; HEART RATE; HUMAN; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FLUTTER; CASE-CONTROL STUDIES; CATHETER ABLATION; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEMALE; FLECAINIDE; HEART ATRIA; HEART CONDUCTION SYSTEM; HEART VENTRICLES; HUMANS; IMIDAZOLES; LIDOCAINE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 44649167679     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eun012     Document Type: Article

References (17)

1. Marcus FI. The hazards of using type Ic antiarrhythmic drugs for the treatment of paroxysmal atrial fibrillation. Am J Cardiol 1990;66:366-7.
2. Friedman PL, Stevenson WG. Proarrhythmia. Am J Cardiol 1998;82:50N-58N.
3. Kawabata M, Hirao K, Horikawa T, Suzuki K, Motokawa K, Suzuki F et al. Syncope in patients with atrial flutter during treatment with class Ic antiarrhythmic drugs. J Electrocardiol 2001;34:65-72.
4. Wiesfeld AC, Ansink JM, van Veldhuisen DJ, van Gelder IC. Broad complex tachycardia during treatment of atrial fibrillation with a 1c antiarrhythmic drug: ventricular or supraventricular proarrhythmia? Int J Cardiol 2006;107:140-1.
5. Feld GK, Chen PS, Nicod P, Fleck P, Meyer D. Possible atrial proarrhythmic effects of class Ic antiarrhythmic drugs. Am J Cardiol 1990;66:378-83.
6. Aouate P, Elbaz N, Klug D, Lacotte J, Raguin D, Frank R et al. Atrial flutter with 1/1 nodo-ventricular conduction with amiodarone from physiopathology to diagnosis. Arch Mal Coeur Vaiss 2002;95:1181-7. (in French).
7. Brembilla-Perrot B, Houriez P, Claudon O, Yassine M, Suty-Selton C, Vancon AC et al. Can the supraventricular proarrhythmic effects of class 1C antiarrhythmic drugs be prevented with the association of beta blockers? Ann Cardiol Angeiol (Paris) 2000;49:439-42. (in French).
8. Velebit V, Podrid P, Lown B, Cohen BH, Graboys TB. Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs. Circulation 1982;65:886-94.
9. Torres V, Flowers D, Somberg JC. The arrhythmogenicity of antiarrhythmic agents. Am Heart J 1985;109:1090-4.
10. Creamer JE, Nathan AW, Camm AJ. The proarrhythmic effects of antiarrhythmic drugs. Am Heart J 1987;114:397-406.
11. Kerin NZ, Somberg S. Proarrhythmia: definition, risk factors, causes, treatment and controversies. Am Heart J 1994;126:575-85.
12. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. New Engl J Med 1989;321:406-12.
13. Kennelly BM, Lane GK. Electrophysiological studies in four patients with atrial flutter with 1:1 atrioventricular conduction. Am Heart J 1978;96:723-30.
14. Aranda JM, Moleiro F, Castellanos A, Befeler B. Electrophysiologic studies in a patient with atrial flutter and 1:1 atrioventricular conduction. Chest 1975;68:200-4.
15. Castellanos A, Vagueiro MC, Befeler B, Myerburg RJ. Syndrome of short P-R, narrow QRS and repetitive supraventricular tachyarrhythmias: the possible occurrence of the R-on-T phenomenon and the limits of this syndrome. Eur J Cardiol 1975;2:337-42.
16. Lister JW, Stein E, Kosowsky BD, Lau SH, Damato AN. Atrioventricular conduction in man. Effect of rate, exercise, isoproterenol and atropine on the P-R interval. Am J Cardiol 1965;16:516-23.
17. Brembilla-Perrot B, Houriez P, Beurrier D, Claudon O, Terrier de la Chaise A, Louis P. Predictors of atrial flutter with 1:1 conduction in patients treated with class I antiarrhythmic drugs for atrial tachyarrhythmias. Int J Cardiol 2001;80:7-15.